A fresh drug target for multiple epithelial tumors discovered by Compugen Compugen Ltd.

Also, of main significance for us may be the known fact that people have reached the point where we are now using multiple predictive capabilities in combination to do this. The today very thrilling discovery and validation of CGEN-671 getting announced as well as the oncology target this is the subject of our lately announced collaboration with Bayer Schering Pharma, are great examples of the initial capabilities obtained by combining synergistic predictive platforms, in these cases, substitute splicing and the identification of targets for monoclonal antibodies. In addition, the product candidate discovery platform that led to these oncology target discoveries, along with a large number of other potential mAb drug targets now at various stages of validation, uses both LEADS and MED, two of our most sophisticated infrastructure platforms.Care for the organs given to you by Mother Nature and you won’t need to live the rest you will ever have connected to medical devices that are billed by the hour. Oh, yeah, and did I mention that your very own pancreas works for free? Unlike with an expensive medical device, you don’t have to pay hardly any money to use your own pancreas. But you do possess to focus on your diet, your exercise and various other lifestyle and health options. By the way, with regards to clarifying the tone of this story, I do acknowledge that we now have a relatively small number of people who have problems with type-1 diabetes through no fault of their very own.